Aspen Aerogels (ASPN) Revenue (2013 - 2026)

Aspen Aerogels (ASPN) has reported Revenue for 14 consecutive years, with $49.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue fell 36.11% year-over-year to $49.8 million; the trailing twelve-month figure through Jun 2026 stood at $202.1 million (down 49.12% YoY), and the FY2025 full-year result was $271.1 million, down 40.11% from the prior year.
• Revenue climbed to $49.8 million in Q2 2026 per ASPN's latest filing, from $37.9 million in the prior quarter.
• Across five years, Revenue topped out at $123.1 million in Q4 2024 and bottomed at $36.7 million in Q3 2022.
• Historically, Revenue has averaged $68.4 million across 5 years, with a median of $60.2 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Revenue jumped 144.55% in 2024, then plunged 66.42% in 2025.
• Over 5 years, Revenue stood at $59.6 million in 2022, then surged by 41.28% to $84.2 million in 2023, then jumped by 46.15% to $123.1 million in 2024, then tumbled by 66.42% to $41.3 million in 2025, then increased by 20.59% to $49.8 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $49.8 million, $37.9 million, and $41.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.